SCHEMBL27372235

SCHEMBL27372235

NS(=O)(=O)c1cccc(C2=CCOCC2)c1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 10/20 0.46
▸ CA1 P00915 9/20 0.46
▸ PIK3CD O00329 4/20 0.46
▸ PIK3CA P42336 4/20 0.46
▸ PIK3CB P42338 2/20 0.46
▸ PIK3CG P48736 2/20 0.46
▸ CA9 Q16790 8/20 0.44
▸ CA13 Q8N1Q1 3/20 0.44
▸ PIK3R1 P27986 1/20 0.43
▸ CA12 O43570 5/20 0.42
▸ CA4 P22748 2/20 0.42
▸ CA7 P43166 1/20 0.42
▸ FABP7 O15540 1/20 0.41
▸ CA14 Q9ULX7 1/20 0.41
▸ MAOB P27338 3/20 0.41
▸ MAOA P21397 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30072245 0.76 FABP7 (0.45) PIK3CDPIK3CAPIK3CBPIK3CGFABP7
SCHEMBL1570328 0.76 FABP7 (0.45) PIK3CDPIK3CAPIK3CBPIK3CGFABP7
SCHEMBL30755522 0.76 CA2 (0.48) CA2CA1CA9CA13CA12
SCHEMBL27372053 0.76 CA2 (0.48) CA2CA1CA9CA13CA12
SCHEMBL932928 0.73 PIK3CD (0.45) PIK3CDPIK3CAPIK3CBPIK3CGFABP7
SCHEMBL18857842 0.73 MAPK14 (0.47) PIK3CDPIK3CAPIK3CBPIK3CGPIK3R1
SCHEMBL29964798 0.73 FABP7 (0.43) CA2CA1PIK3CDPIK3CAPIK3CB
SCHEMBL31705648 0.72 FABP7 (0.53) PIK3CDPIK3CAFABP7
SCHEMBL3107969 0.72 FABP7 (0.53) PIK3CDPIK3CAFABP7
SCHEMBL31525680 0.71 CA2 (0.48) CA2CA1PIK3CDPIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4562016-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME Cedilla Therapeutics, Inc. (US) 2025-06-04 — — EP disclosed
WO-2024026483-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME CEDILLA THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
WO-2024026483-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME CEDILLA THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback